Overview

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A study to demonstrate the superiority of test article nasal spray relative to vehicle nasal spray for the treatment of seasonal allergic rhinitis for a 2 week period in patients aged 6 to 11 years with a history of seasonal allergic rhinitis.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Olopatadine Hydrochloride